Terms: = Gastric cancer AND TPR, P12270, 7175 AND Treatment
8 results:
1. Discovery of D6808, a Highly Selective and Potent Macrocyclic c-Met Inhibitor for gastric cancer Harboring
Wang C; Li J; Qu L; Tang X; Song X; Yang F; Chen X; Lin Q; Lin W; Zhou Y; Tu Z; Chen Y; Zhang Z; Lu X
J Med Chem; 2022 Nov; 65(22):15140-15164. PubMed ID: 36355693
[No Abstract] [Full Text] [Related]
2. Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis.
Liu T; Liu D; Jin Y; Dong M
Immunopharmacol Immunotoxicol; 2022 Dec; 44(6):809-815. PubMed ID: 35708278
[TBL] [Abstract] [Full Text] [Related]
3. Segmentation of gastric Computerized Tomography Images under Intelligent Algorithms in Evaluation of Efficacy of Decitabine Combined with Paclitaxel in treatment of gastric cancer.
Ge Z; Wang M; Liu Q
J Healthc Eng; 2021; 2021():8023490. PubMed ID: 34745511
[TBL] [Abstract] [Full Text] [Related]
4. Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.
Willis J; Lefterova MI; Artyomenko A; Kasi PM; Nakamura Y; Mody K; Catenacci DVT; Fakih M; Barbacioru C; Zhao J; Sikora M; Fairclough SR; Lee H; Kim KM; Kim ST; Kim J; Gavino D; Benavides M; Peled N; Nguyen T; Cusnir M; Eskander RN; Azzi G; Yoshino T; Banks KC; Raymond VM; Lanman RB; Chudova DI; Talasaz A; Kopetz S; Lee J; Odegaard JI
Clin Cancer Res; 2019 Dec; 25(23):7035-7045. PubMed ID: 31383735
[TBL] [Abstract] [Full Text] [Related]
5. TRP channels in gastric cancer: New hopes and clinical perspectives.
Sterea AM; Egom EE; El Hiani Y
Cell Calcium; 2019 Sep; 82():102053. PubMed ID: 31279156
[TBL] [Abstract] [Full Text] [Related]
6. KATZLDA: KATZ measure for the lncRNA-disease association prediction.
Chen X
Sci Rep; 2015 Nov; 5():16840. PubMed ID: 26577439
[TBL] [Abstract] [Full Text] [Related]
7. Designed hybrid tpr peptide targeting Hsp90 as a novel anticancer agent.
Horibe T; Kohno M; Haramoto M; Ohara K; Kawakami K
J Transl Med; 2011 Jan; 9():8. PubMed ID: 21235734
[TBL] [Abstract] [Full Text] [Related]
8. K252a inhibits the oncogenic properties of Met, the HGF receptor.
Morotti A; Mila S; Accornero P; Tagliabue E; Ponzetto C
Oncogene; 2002 Jul; 21(32):4885-93. PubMed ID: 12118367
[TBL] [Abstract] [Full Text] [Related]
